Evidence map›Paper›PMID 22198062›Full record

ReviewPulmonary pharmacology & therapeutics2012

Role of epithelial mucins during airway infection.

Kwang Chul Kim

Abstract readReview
In one paragraph

Review in Pulmonary pharmacology & therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Bacterial SEAL domains undergo autoproteolysis and function in regulated intramembrane proteolysis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The seven constitutive respiratory defense barriers against SARS-CoV-2 infection.Revista da Sociedade Brasileira de Medicina Tropical · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Mucins and their receptors in chronic lung disease.Clinical & translational immunology · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kwang Chul KimLung Mucus Research Program, Center for Inflammation, Translational and Clinical Lung Research and Department of Physiology, Temple University School of Medicine, 3420 N. Broad Street, MRB-410, Philadelphia, PA 19140, USA. kckim@temple.edu
Temple Lung Center · US

Funding

SIGNALING MECHANISM OF MUC1 MUCINR01HL047125 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI KIM, KWANG CHUL · 1991 to 2015
$4.5M
Anti-inflammatory role of MUC1 mucinR01HL081825 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KIM, KWANG CHUL · 2006 to 2010
$2.2M
NHLBI NIH HHS R01 HL047125NHLBI NIH HHS R01 HL081825NHLBI NIH HHS R01 HL-47125NHLBI NIH HHS R01 HL-81825
6 · The paper itself

Abstract

Airway surface fluid contains two layers of mucins consisting mainly of 5 different mucin gene products. While the outer layer contains two gel-forming mucins (MUC5AC and MUC5B) that are tightly associated with various biologically active, defensive molecules, the inner layer contains three membrane-tethered mucins (MUC1, MUC4 and MUC16) shed from the apical cell surface. During airway infection, all of these mucins serve as a major protective barrier against pathogens. MUC1 mucin produced by virtually all the surface columnar epithelial cells in the respiratory tract as well as Type II pneumocytes in the alveoli plays an additional, perhaps more critical role during respiratory infection by controlling the resolution of inflammation that is essential to prevent the development of inflammatory lung disease.

Indexed as

Alveolar Epithelial CellsAnimalsHumansInflammationLung DiseasesMucinsPulmonary AlveoliRespiratory MucosaRespiratory Tract InfectionsMucins

Identifiers

PMID22198062
PMCPMC3342466
OpenAlexW2088202934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.